(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VITAVITRO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VITAVITRO

ST13

US500000079251809

Class

5, 10, 44

Filing

79251809

Registration

5969712

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

06/09/2026

Trademark type

Combined

Nice classes

5, 10, 44

Filing date

07/26/2018

Registration date

01/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/21/2026

Last transaction

06/09/2026

Responsible office

United States Patent and Trademark Office

Status code

707

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

CN

Examiner

WILSON, MARYNELLE WEST

Current location

Historical data usage

Mark description

The mark consists of a stylized letter "V" followed by the stylized wording "VITAVITRO".

Holders and representatives

Holders

Shenzhen VitaVitro Biotech Co., Ltd.
Shenzhen Vitavitro Biotech Co., Ltd

Representatives

James A. Power Jr Power Del Valle LLP

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for enhancing fertility and treating fertility related conditions; Pharmaceutical preparations for enhancing fertility and treating fertility related conditionsvitrification medium for cryopreservation of embryoseggs and spermwarming medium for use with cryopreserved embryoseggs and spermin vitro fertilization mediumflushing buffer medium for use in enhancing fertility and treating fertility related conditionsgamete buffer mediumculture medium for enhancing fertility and treating fertility related conditions; biological tissue cultures for medical purposes; semen for artificial insemination; cultures of microorganisms for medical and veterinary use; dietetic foods adapted for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary use ; preparations for the diagnosis of pregnancy; hormones for medical purposes; moth balls

Class 10

Testing apparatus for medical purposesblood testing apparatushormone testing apparatusDNA testing apparatusreproduction organs testing apparatussperm motility testing apparatus; diagnostic apparatus for medical purposesblood testing apparatushormone testing apparatusDNA testing apparatussperm motility test apparatus; electric belts for medical purposes; medical apparatus and instrumentsautomatic vitrification machines for cryopreservation of embryoseggs and spermincubatorssingle lumen ovum pick-up needledouble lumen ovum pick-up needleembryo transfer cathetersembryo culture dishes; open- pulled straw for use in cryopreservation of embryoseggs and sperm; vaginal syringes; incubators for medical purposes; cases fitted for medical instruments; uterine syringes; belts for medical purposes; syringes for medical purposes

Class 44

In vitro fertilization services; hospital services; medical assistance; pharmacy adviceadvice in the performance of in vitro fertilizationhow to prepare for in vitro fertilization surgeryregarding proper diet and exercise accompanying in vitro fertilization; artificial insemination services; health counseling; veterinary assistanceassisting a veterinarian in embryo transfersperm preservationegg and embryo preservation

Publications

History of USPTO decisions and trademark events.

38 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

05/21/2026

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

05/21/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/18/2026

ES71

TEAS SECTION 71 RECEIVED

01/28/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/02/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/28/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/29/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/12/2020

FIMP

FINAL DISPOSITION PROCESSED

05/12/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/28/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/06/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2020

GPNX

NOTIFICATION PROCESSED BY IB

11/22/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/15/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/12/2019

PUBO

PUBLISHED FOR OPPOSITION

11/12/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/23/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/23/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/23/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/10/2019

ALIE

ASSIGNED TO LIE

10/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/08/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

10/08/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/08/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

10/08/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/17/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/17/2019

RFNT

REFUSAL PROCESSED BY IB

04/05/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/20/2019

RFRR

REFUSAL PROCESSED BY MPU

03/20/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/12/2019

CNRT

NON-FINAL ACTION WRITTEN

03/11/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/05/2019

DOCK

ASSIGNED TO EXAMINER

02/28/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/28/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/14/2019

Continuous trademark protection

Get notified about every new filing that threatens VITAVITRO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.